Dysregulation of IGF signaling was reported to be involved in many types of age-related diseases including neurodegenerative disease such as late-onset Alzheimer's disease and familial Parkinson's diseases along with the diabetes, cancer, arteriosclerosis, and osteoporosis [31, 34–36]. Here, IGF1 is linked to Alzheimer disease.